The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experience

Jayesh Desai1, Christina Guo2, Ben Tran2

  • 1Early Drug Development Program and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Jayesh.Desai@petermac.org.

Insights

Peter MacCallum Cancer Centre enhances patient outcomes through translational research and early phase clinical trials. Collaboration with local, regional, and global networks is crucial for success in Australia's evolving drug development landscape.

Area of Science:

  • Oncology
  • Translational Research
  • Clinical Trials

Background:

  • Peter MacCallum Cancer Centre prioritizes translational research for improved patient outcomes.
  • A strong clinical trials program, with a focus on early phase trials, is central to this mission.
  • Developing a world-class early phase trials program relies on strategic network creation and collaboration.

Purpose of the Study:

  • To articulate the evolution of the early drug development landscape in Australia.
  • To explain the critical role of collaboration in the success of early phase trials.
  • To highlight the strategies employed by Peter MacCallum Cancer Centre in fostering collaborative networks.

Main Methods:

  • Review of the Australian early drug development landscape.
  • Analysis of the impact of network collaboration on clinical trial success.
  • Case study of Peter MacCallum Cancer Centre's approach to building research networks.

Main Results:

  • The early drug development sector in Australia has undergone significant evolution.
  • Collaboration is a key enabler for the success of early phase cancer trials.
  • Strategic network development is essential for a robust clinical trials program.

Conclusions:

  • Translational research and early phase trials are vital for advancing cancer care.
  • Effective collaboration across local, regional, and global networks is paramount.
  • Peter MacCallum Cancer Centre's success is underpinned by its commitment to collaborative research initiatives.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
399
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.7K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Network Covalent Solids02:18

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K